.png)
Regeneron's Eylea injection therapy is a groundbreaking treatment for various eye conditions. If you or a loved one are considering this treatment, here are 10 key things you need to know:
- Eylea is FDA-approved for treating wet age-related macular degeneration (AMD), diabetic macular edema, and macular edema following retinal vein occlusion.
- The injection is administered directly into the eye by a healthcare professional, typically every 4-8 weeks depending on the condition being treated.
- Eylea works by blocking a protein called vascular endothelial growth factor (VEGF) that can contribute to abnormal blood vessel growth and leakage in the eye.
- Common side effects of Eylea injections include temporary eye irritation, redness, or discomfort at the injection site. Serious side effects are rare but can include eye infections or detached retinas.
- It's important to follow your doctor's instructions for scheduling and receiving Eylea injections to ensure the best possible outcomes for your eye condition.
- Some patients may experience improved vision within a few days of receiving their first Eylea injection, while others may require multiple injections before seeing significant improvement.
- Eylea injections are typically covered by insurance for the FDA-approved conditions, but it's important to check with your insurance provider to confirm coverage and any out-of-pocket costs.
- Your doctor will monitor your eye health and vision regularly while you are receiving Eylea injections to assess the treatment's effectiveness and make any necessary adjustments.
- If you have any concerns or questions about Eylea injection therapy, don't hesitate to discuss them with your eye care provider. They can provide personalized guidance and support throughout your treatment.
- Overall, Eylea injection therapy has been shown to be safe and effective for many patients with AMD, diabetic macular edema, and retinal vein occlusion. Talk to your doctor to see if this treatment may be right for you.